The Editor of the Annals ofthe Rheumatic Diseases has kindly suggested that I should write a note in this issue about the journal with which he and I have been so closely associated now for many years. What has prompted him to do this is the fact that in 1963 we shall be publishing six issues of the Annals yearly, instead of four. This change from quarterly to bimonthly frequency has been made in many of the other specialist journals brought out by the British Medical Association under the publishing wing of the British Medical Journal. It is a step we take with some caution, because it means more work for the editorial and managerial departments of the B.M.J., and an increased subscription; and in particular it implies a faith in the advancement of knowledge of the specialty to which the journal is devoted.
The reader will notice that the title of the Annals remains the same, and I hope it will be many years yet before the term "rheumatic diseases" is entirely replaced by the term "rheumatology". But The enormous stimulus given to the study of the rheumatic diseases by workers on both sides of the Atlantic, and by Dr. Philip S. Hench in particular, has led to more research, more knowledge, and the publication of more papers. One sign of this is the increasing number of good papers submitted to the editor of the Annals ofthe Rheumatic Diseases. This has at last necessitated our increasing the frequency of its publication from four to six times a year, accompanied by a necessary, but modest, increase in subscription.
When some years ago I told a learned friend of mine that we thought of bringing out still another specialist publication he surprised me by saying: "Much better do that than establish a new chair in a university, to be filled by a professor who will sit on it for the rest of his life and do little else. An editor has to edit his journal, and if it is well done it will stimulate the production of work." Backed by a strong editorial committee, Dr. Copeman has had the satisfaction of witnessing the proof of the latter part of this statement and of seeing the Annals go from strength to strength and become a potent stimulus to the subject he has made his own. But my learned friend would not be surprised to find exceptions to his rule: Dr. Copeman's editorial committee is as valuable as it is not least because of the professors on it.
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